Q1 Earnings Estimate for Abacus Life Issued By B. Riley

Abacus Life, Inc. (NASDAQ:ABL) – Investment analysts at B. Riley issued their Q1 2025 earnings estimates for Abacus Life in a research report issued on Monday, November 25th. B. Riley analyst M. Howlett expects that the company will post earnings per share of $0.25 for the quarter. B. Riley currently has a “Buy” rating and a $17.00 target price on the stock. The consensus estimate for Abacus Life’s current full-year earnings is $0.64 per share. B. Riley also issued estimates for Abacus Life’s Q2 2025 earnings at $0.26 EPS, Q3 2025 earnings at $0.27 EPS, Q4 2025 earnings at $0.27 EPS, FY2025 earnings at $1.05 EPS, Q1 2026 earnings at $0.36 EPS, Q2 2026 earnings at $0.38 EPS, Q3 2026 earnings at $0.40 EPS and FY2026 earnings at $1.56 EPS.

ABL has been the topic of a number of other reports. B. Riley Financial restated a “buy” rating and set a $16.00 price target on shares of Abacus Life in a research report on Friday, August 30th. Northland Securities started coverage on shares of Abacus Life in a research note on Thursday, October 24th. They issued an “outperform” rating and a $13.50 price target on the stock. Piper Sandler reaffirmed an “overweight” rating and set a $13.00 target price (up from $12.00) on shares of Abacus Life in a research note on Friday, November 8th. TD Cowen began coverage on shares of Abacus Life in a report on Wednesday, August 7th. They issued a “buy” rating and a $14.00 target price for the company. Finally, Northland Capmk upgraded shares of Abacus Life to a “strong-buy” rating in a research note on Thursday, October 24th. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $14.70.

Abacus Life Stock Performance

ABL opened at $8.08 on Wednesday. The firm has a market capitalization of $603.17 million, a PE ratio of -43.44 and a beta of 0.15. Abacus Life has a twelve month low of $6.56 and a twelve month high of $13.25. The firm’s 50-day moving average price is $9.22 and its 200 day moving average price is $9.75. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.65.

Abacus Life (NASDAQ:ABL) last announced its earnings results on Thursday, November 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.06. Abacus Life had a negative net margin of 11.65% and a positive return on equity of 12.88%. The business had revenue of $28.15 million for the quarter, compared to analyst estimates of $26.08 million. During the same quarter last year, the business earned $0.01 earnings per share.

Insider Activity

In other Abacus Life news, insider Matthew Ganovsky sold 156,250 shares of Abacus Life stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $8.00, for a total value of $1,250,000.00. Following the completion of the transaction, the insider now owns 10,847,047 shares of the company’s stock, valued at $86,776,376. The trade was a 1.42 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Jay J. Jackson sold 2,031,250 shares of the business’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $8.00, for a total transaction of $16,250,000.00. Following the transaction, the chief executive officer now directly owns 10,562,000 shares of the company’s stock, valued at approximately $84,496,000. This trade represents a 16.13 % decrease in their position. The disclosure for this sale can be found here. Insiders own 79.20% of the company’s stock.

Institutional Investors Weigh In On Abacus Life

Several institutional investors have recently bought and sold shares of the stock. Richard W. Paul & Associates LLC raised its holdings in Abacus Life by 4.8% during the 2nd quarter. Richard W. Paul & Associates LLC now owns 30,448 shares of the company’s stock worth $263,000 after buying an additional 1,401 shares during the period. Allspring Global Investments Holdings LLC acquired a new position in Abacus Life during the second quarter valued at approximately $9,909,000. Principal Financial Group Inc. acquired a new position in Abacus Life during the second quarter valued at approximately $8,105,000. Stieven Capital Advisors L.P. acquired a new position in Abacus Life during the second quarter valued at approximately $2,811,000. Finally, Levin Capital Strategies L.P. acquired a new position in Abacus Life during the second quarter valued at approximately $130,000.

About Abacus Life

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.